Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07134465) titled 'Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Haisco Pharmaceutical Group Co., Ltd.
Condition:
Healthy Subjects
Intervention:
Drug: HSK31858 Tablets and Itraconazole Capsules
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: August 11, 2025
Target Sample Size: 24
Countries of Recruitment:
China
To know more, visit https://clinicalt...